This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 2012-2020.
Company Filing History:
Years Active: 2012-2020
Title: Michelle Ann Schmidt: Innovator in Pharmaceutical Chemistry
Introduction
Michelle Ann Schmidt is a prominent inventor based in Millstadt, IL (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of Bruton's tyrosine kinase inhibitors. With a total of 3 patents to her name, Schmidt's work has the potential to impact the treatment of various diseases.
Latest Patents
Schmidt's latest patents focus on compounds that form covalent bonds with Bruton's tyrosine kinase (BTK). These patents disclose methods for the preparation of these compounds, as well as pharmaceutical compositions that include them. The methods of using BTK inhibitors are detailed, highlighting their application in treating autoimmune diseases, heteroimmune diseases, cancer (including lymphoma), and inflammatory diseases.
Career Highlights
Michelle Ann Schmidt is currently associated with Pfizer Corporation, where she continues to advance her research in pharmaceutical innovations. Her work is characterized by a commitment to developing effective therapeutic agents that address critical health challenges.
Collaborations
Throughout her career, Schmidt has collaborated with notable colleagues, including Margaret Lanahan Grapperhaus and John Robert Springer. These partnerships have contributed to her success in the field and the advancement of her research.
Conclusion
Michelle Ann Schmidt's innovative work in the development of Bruton's tyrosine kinase inhibitors showcases her dedication to improving healthcare through pharmaceutical advancements. Her contributions are paving the way for new treatment options for various diseases.